CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results. uri icon

authors

  • Park, Jae H
  • Perales, Miguel-Angel
  • Shouval, Roni
  • Tomas, Ana Alarcon
  • Cathcart, Elizabeth
  • Mead, Elena
  • Santomasso, Bianca
  • Holodny, Andrei
  • Brentjens, Renier J
  • Riviere, Isabelle
  • Sadelain, Michel
  • Nath, Karthik
  • Devlin, Sean M
  • Sauter, Craig S
  • Palomba, M Lia
  • Shah, Gunjan
  • Dahi, Parastoo
  • Richard J Lin, MD, PhD
  • Scordo, Michael

publication date

  • January 1, 2023